User:Mr. Ibrahem/Zavegepant

Zavegepant, sold under the brand name Zavzpret, is a medication used to treat migraine headaches. It is used for the headache itself, rather than prevention. It is sprayed into the nose.

Common side effects include taste changes, nausea, sore nose, and vomiting. Other side effects include allergic reactions. Use is not recommended in people with significant liver or kidney problems. Safety in pregnancy is unclear. It is a calcitonin gene-related peptide receptor antagonist.

Zavegepant was approved for medical use in the United States in 2023. It is expected to become commercially available in July of 2023 and be priced similar to other medications in its class.